Delayed-release Formulation Evaluation

Delayed-Release Formulation Evaluation is a systematic analytical framework used in pharmaceutical bioequivalence assessment that specifically characterizes the in vitro and in vivo performance of dosage forms designed to release the active ingredient after a predetermined lag period, thereby differentiating them from immediate- and extended-release formulations.

99

Publications

3.7K

Citations

536

Authors

217

Institutions

Publications per year

2017–2026

14

Publications

99

Authors

536

  1. SA
    Stuart Atkinson

    Takeda (United States), United States

    4 publications · 153 citations

    4

    h-index

  2. SD
    Sandeep Dutta

    Abbott Fund, United States

    3 publications · 127 citations

    3

    h-index

  3. MV
    Majid Vakily

    University of Alberta, Canada

    3 publications · 135 citations

    3

    h-index

  4. RL
    Raymond L. Hintz

    Stanford University, United States

    3 publications · 131 citations

    3

    h-index

  5. DJ
    Darcy J. Mulford

    Takeda (United States), United States

    3 publications · 135 citations

    3

    h-index

1–5 of 536

Venues

  1. PubMed

    Repository · 7 publications · 145 citations

    7

    h-index

  2. Journal of Controlled Release

    6 publications · 376 citations

    6

    h-index

  3. Journal of Pharmaceutical Sciences

    5 publications · 141 citations

    5

    h-index

  4. Journal of Dairy Science

    JDS · 4 publications · 155 citations

    4

    h-index

  5. The American Journal of Gastroenterology

    AJG · 3 publications · 100 citations

    3

    h-index

1–5